Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymp Node Positive Breast Cancer: A Pilot Study

NCT00378638 is registered in ClinicalTrials.gov with Chap, Linnea I., M.D. as lead sponsor.

NCT NCT00378638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00378638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymp Node Positive Breast Cancer: A Pilot Study
Lead sponsor
Chap, Linnea I., M.D.
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2006
Completion date
October 31, 2008
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer